Associate Marketing Director, Zanzalintinib CRC Launch – Promotions

Alameda, CA (On-site)

$179K/yr – $253K/yrMid Level9+ years expFull time

Posted 5 weeks ago

Get ahead of other applicants

Do these before or after applying to Exelixis to increase your chances.

Job Summary

Original Job Description

Exelixis logo

Exelixis

2.0 Glassdoor

Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. Cancer is our cause. Make it yours, too. Please see our Community Guidelines: bit.ly/4iBzJU0For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.

Founded in 1994
Alameda, California, USA
1.5K employees (92 in marketing)
11% recommend to a friend
9% CEO approval

Traffic Signals

Monthly Visitors
37.4K
Monthly Google Ads Budget
$10.2K
Traffic Source Mix
Search
59.3%
Direct
33.2%
Referral
6.3%
Social
0.5%
Paid
0.7%

Headcount Trend

Current headcount: ~1.5K

Marketing Team

Marketing Team Size
86 (6% of company)
Median Career Experience
21 years
Median Tenure
4 years
Marketing Roles Posted (Last 30 Days)
3

Funding

Total Funding
$514M
Last Raise
$135M
Post IPO Equity, 11 years ago

Funding History

  • Jul 2015
    Post IPO Equity • $135M
  • Feb 2012
    Post IPO Equity • $65M
  • Jun 2010
    Post IPO Debt • $160M

Recent News